NASDAQ:EXAS - Exact Sciences Corporation
$104.90
 $-1.81
-1.70%
4:00PM EDT
2019-09-16
Exact Sciences Corporation is a molecular diagnostics company. The Company focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer. Its Cologuard test is a stool-based deoxyribonucleic acid (sDNA) screening test, which utilizes a multi-target approach to detect deoxyribonucleic acid (DNA) and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Cologuard test is intended for the qualitative detection of colorectal neoplasia associated DNA markers and for the presence of occult hemoglobin in human stool. It focuses on the development of additional tests for other types of cancer. It is developing a blood-based biomarker test to aid in the early detection of lung cancer in individuals with lung nodules discovered through a computerized tomography (CT) or other scan. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  EXAS     avg for
industry  
  avg for
sector  
42 stocks weight:  135. 41   0. 00   0. 00  
42 stocks rank:  2. 20 K 1. 97 K 1. 30 K
# analyst opinions:  9. 00   12. 84   12. 97  
mean recommendation:  1. 50   2. 12   2. 07  

quick ratio:  2. 65   5. 11   1. 92  
current ratio:  2. 79   5. 50   2. 45  

target price low:  127. 00   79. 53   109. 66  
target price avg:  133. 44   100. 11   131. 81  
target price high:  143. 00   126. 46   149. 31  
1-yr high:  122. 49   104. 28   134. 46  
last close:  104. 41   77. 07   117. 08  
50-day avg:  116. 46   79. 01   117. 12  
200-day avg:  96. 65   81. 51   113. 76  
1-yr low:  56. 04   62. 18   93. 76  
volume:  1. 03 M 2. 53 M 3. 04 M
50-day avg volume:  1. 61 M 3. 41 M 4. 09 M
200-day avg volume:  1. 71 M 3. 18 M 4. 63 M

1-day return:  1. 21 % -0. 17 % 0. 18 %
this week return:  -2. 16 % 0. 31 % 0. 77 %
12-wk return:  -11. 55 % -0. 76 % 2. 99 %
52-wk return:  48. 22 % -5. 78 % 4. 64 %

enterprise value (EV):  13. 40 B 44. 28 B 112. 94 B
market cap:  13. 58 B 500. 31 B 4. 95 T
EBITDA:  -164. 19 M 4. 78 B 7. 74 B
enterprise multiple (EV/EBITDA):  -81. 64   2. 41   10. 42  
enterprise/revenue (EV/R):  21. 51   150. 10   22. 18  
total revenue:  623. 19 M 10. 73 B 31. 64 B
total debt:  826. 64 M 11. 92 B 16. 97 B
debt/equity:  107. 98   244. 15   141. 17  
net income (common):  -220. 82 M 1. 86 B 3. 90 B

shares outstanding:  129. 49 M 579. 09 M 1. 27 B
shares:  127. 57 M 584. 68 M 1. 22 B
shares short:  11. 18 M 16. 45 M 13. 52 M
shares short prior month:  12. 90 M 15. 17 M 12. 50 M
short ratio:  5. 65   6. 82   3. 68  
short % of float:  8. 78 % 7. 00 % 2. 78 %
total cash/share:  9. 57   10. 27   8. 82  
total cash:  1. 24 B 6. 23 B 5. 99 B
free cash flow:  -165. 05 M 2. 91 B 4. 78 B
operating cash flow:  -62. 53 M 4. 10 B 5. 77 B

book value:  5. 92   13. 01   26. 68  
price/book:  17. 64   -9. 86   6. 12  
gross profits:  336. 48 M 8. 13 B 35. 94 B
operating margins:  -30. 85 % -1246. 94 % -202. 61 %
EBITDA margins:  -26. 35 % 7. 07 % 24. 32 %
profit margins:  -35. 43 % 3. 12 % 14. 56 %
gross margins:  73. 84 % 44. 41 % 58. 52 %

1-yr max volatility:  14. 64 % --- ---
1-yr mean volatility:  2. 31 % 1. 19 % 0. 86 %

1-yr EPS:  -1. 76   1. 30   4. 02  
forward EPS:  -0. 83   3. 42   6. 65  
P/E:  -59. 22   15. 96   23. 91  
forward P/E:  -128. 57   -4. 28   12. 40  
PE/G:  -0. 63   1. 02   -1. 71  
growth:  94. 20 % 218. 69 % 102. 21 %
earnings high:  -0. 25   1. 22   1. 61  
earnings avg:  -0. 39   0. 85   1. 50  
earnings low:  -0. 48   0. 55   1. 39  
revenue high:  221. 20 M 2. 88 B 8. 82 B
revenue avg:  216. 12 M 2. 80 B 8. 66 B
revenue low:  213. 00 M 2. 75 B 8. 48 B
return on assets:  -7. 36 % -2. 87 % 5. 55 %
return on equity:  -29. 25 % -28. 69 % 20. 45 %
revenue growth:  94. 20 % 222. 79 % 39. 99 %
revenue/share:  4. 97   13. 15   52. 14  

beta (1yr vs S&P500):  1. 76   1. 20   0. 87  
sharpe (1yr):  0. 88   -0. 09   0. 48  

held % insiders:  2. 00 % 6. 78 % 3. 59 %
held % institutions:  90. 27 % 76. 29 % 67. 25 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-09-16 : EXAS
.    144.987 =         144.987 :: --> INITIAL WEIGHT <--
.                               --> FUNDAMENTALS <--
.    x 0.865 =         125.451 :: P/E factor
.    x 1.123 =         140.885 :: PE/G factor
.    x 1.565 =         220.467 :: beta factor
.    x 0.983 =         216.684 :: sharpe factor
.    x 1.624 =         351.859 :: current ratio factor
.    x 0.945 =         332.364 :: quick ratio factor
.    x 1.106 =         367.582 :: short ratio factor
.    x 1.604 =         589.538 :: revenue growth factor
.    x 1.968 =        1160.033 :: EV/R factor
.    x 1.156 =        1341.038 :: price-to-book factor
.    x 0.965 =        1294.617 :: debt-to-revenue factor
.    x 1.707 =        2210.535 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.037 =        4503.929 :: sector+industry 1-year gains factor
.    x 0.979 =        4407.713 :: industry 12-weeks return factor
.    x 1.315 =        5797.821 :: industry 2-weeks return factor
.    x 1.369 =        7936.942 :: company one-year gains+dividend factor
.    x 2.043 =       16216.102 :: company 13 weeks' performance factor
.    x 1.224 =       19852.044 :: 5-day avg > 200-day avg
.    x 1.205 =       23921.384 :: 50-day avg > 200-day avg
.    x 0.995 =       23809.097 :: "drift" penalty 3 days ago
.    x 4.186 =       99658.874 :: overall "drift" factor
.    x 0.907 =       90405.493 :: largest single-day price delta factor
.    x 0.997 =       90111.903 :: volatility factor
.    x 0.998 =       89901.343 :: 42-day volatility factor
.     x 2.12 =      190582.975 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.865 =      164903.862 :: forward P/E factor
.    x 1.183 =      195100.297 :: industry recommendation factor
.    x 3.103 =      605451.803 :: company recommendation factor
.    x 1.006 =       609376.54 :: factor historical industry gain for week 37
.    x 1.577 =      961055.004 :: target low factor
.    x 1.176 =     1129974.377 :: target mean factor
.    x 1.026 =     1158826.928 :: target high factor
.   x 10.647 =    12338551.418 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =          59.267 :: reduced for readability
.   + 76.146 =         135.413 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                    135.413 :: FINAL WEIGHT for NASDAQ:EXAS


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org